Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Ibrahim

Showing results (431-440 of 460) with videos related to

Pageof 46
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2020
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney DonorsDidier A Mandelbrot, Peter P Reese, Neetika Garg, et al.
Diabetes, Obesity & Metabolism|February 16, 2010
Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in miceM Perreault, S Will, D Panza, et al.
International Journal of Nanomedicine|October 9, 2023
<i>Arthrospira platensis</i> Nanoparticles Mitigate Aging-Related Oxidative Injured Brain Induced by D-galactose in Rats Through Antioxidants, Anti-Inflammatory, and MAPK PathwaysHeba I Ghamry, Mustafa Shukry, Mohamed A Kassab, et al.
BMC Neurology|June 29, 2026
Impact of migraine on work productivity of healthcare providers at Kasr Al-Ainy HospitalWesam Osama, Rehab Magdy, Salsabil Abo Al-Azayem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancerIgnace B Vergote, Agustin Garcia, John Micha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006G V Long, A Arance, L Mortier, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 11, 2009
H5N1 surveillance in migratory birds in Java, IndonesiaArthur C Stoops, Katie A Barbara, Mochamad Indrawan, et al.
Cancer Medicine|March 25, 2018
An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancerJeffrey L Vacirca, Arlene Chan, Klára Mezei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Journal of Pharmaceutical Sciences|January 3, 2013
Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation processNavnit Shah, Raman M Iyer, Hans-Juergen Mair, et al.
Pageof 46

Showing results (431-440 of 460) with videos related to

Sort By:
Pageof 46
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 3, 2020
KDOQI US Commentary on the 2017 KDIGO Clinical Practice Guideline on the Evaluation and Care of Living Kidney DonorsDidier A Mandelbrot, Peter P Reese, Neetika Garg, et al.
Diabetes, Obesity & Metabolism|February 16, 2010
Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in miceM Perreault, S Will, D Panza, et al.
International Journal of Nanomedicine|October 9, 2023
<i>Arthrospira platensis</i> Nanoparticles Mitigate Aging-Related Oxidative Injured Brain Induced by D-galactose in Rats Through Antioxidants, Anti-Inflammatory, and MAPK PathwaysHeba I Ghamry, Mustafa Shukry, Mohamed A Kassab, et al.
BMC Neurology|June 29, 2026
Impact of migraine on work productivity of healthcare providers at Kasr Al-Ainy HospitalWesam Osama, Rehab Magdy, Salsabil Abo Al-Azayem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 2, 2013
Randomized multicenter phase II trial comparing two schedules of etirinotecan pegol (NKTR-102) in women with recurrent platinum-resistant/refractory epithelial ovarian cancerIgnace B Vergote, Agustin Garcia, John Micha, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2021
Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma: analysis from KEYNOTE-006G V Long, A Arance, L Mortier, et al.
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|March 11, 2009
H5N1 surveillance in migratory birds in Java, IndonesiaArthur C Stoops, Katie A Barbara, Mochamad Indrawan, et al.
Cancer Medicine|March 25, 2018
An open-label, dose-ranging study of Rolontis, a novel long-acting myeloid growth factor, in breast cancerJeffrey L Vacirca, Arlene Chan, Klára Mezei, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001O Hamid, C Robert, A Daud, et al.
Journal of Pharmaceutical Sciences|January 3, 2013
Improved human bioavailability of vemurafenib, a practically insoluble drug, using an amorphous polymer-stabilized solid dispersion prepared by a solvent-controlled coprecipitation processNavnit Shah, Raman M Iyer, Hans-Juergen Mair, et al.
Pageof 46